Xiaoying Shen

11.3k total citations · 1 hit paper
83 papers, 1.9k citations indexed

About

Xiaoying Shen is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Xiaoying Shen has authored 83 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Virology, 33 papers in Immunology and 28 papers in Molecular Biology. Recurrent topics in Xiaoying Shen's work include HIV Research and Treatment (46 papers), Immune Cell Function and Interaction (17 papers) and Immunotherapy and Immune Responses (13 papers). Xiaoying Shen is often cited by papers focused on HIV Research and Treatment (46 papers), Immune Cell Function and Interaction (17 papers) and Immunotherapy and Immune Responses (13 papers). Xiaoying Shen collaborates with scholars based in United States, China and United Kingdom. Xiaoying Shen's co-authors include Chih‐Ming Ho, Tak‐Sing Wong, Georgia D. Tomaras, David C. Montefiori, Barton F. Haynes, Hengjun Gao, Daqi Fu, Yunbo Luo, Huaxue Yan and Benzhong Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Circulation.

In The Last Decade

Xiaoying Shen

77 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

2021 222 citations Xiaoying Shen, Haili Tang et al. Cell Host & Microbe profile →

Peers

Countries citing papers authored by Xiaoying Shen

Since Specialization

Citations

This map shows the geographic impact of Xiaoying Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Shen more than expected).

Fields of papers citing papers by Xiaoying Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Shen. The network helps show where Xiaoying Shen may publish in the future.

Co-authorship network of co-authors of Xiaoying Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoying Shen. A scholar is included among the top collaborators of Xiaoying Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoying Shen. Xiaoying Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The political legacy of disease control: Evidence from a polio vaccination campaign in China 2025 ·China Economic Review ·Xiaoying Shen, (unknown), (unknown)	0
2	Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk 2025 ·Signal Transduction and Targeted Therapy ·Yan Ma, Yongjun Wang, Renzheng Chen, Yabin Wang, Yan Fang, Qin Cheng, (unknown), Xiaoying Shen, Tingwen Zhou, Lei Tian, (unknown), Fan Li, (unknown), Dong Han, (unknown)	1
3	Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env 2024 ·Journal of Virology ·Parul Agrawal, Maria L. Knudsen, Anna J. MacCamy, Nicholas K. Hurlburt, Arineh Khechaduri, (unknown), (unknown), (unknown), Andrew B. Stuart, Ilja Bontjer, Xiaoying Shen, David C. Montefiori, Harry B. Gristick, Pamela J. Björkman, (unknown), Marie Pancera, Leonidas Stamatatos	0
4	Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine 2024 ·Open Forum Infectious Diseases ·(unknown), Xiaoying Shen, R. Scott McClelland, Zijun Wang, Stacy Selke, (unknown), (unknown), Christopher L. McClurkan, Erin A. Goecker, Kerry J. Laing, David M. Koelle, Alexander L. Greninger, Michel C. Nussenzweig, David C. Montefiori, Lawrence Corey, Anna Wald	2
5	Correlation of 3'-phosphoadenosine-5'-phosphosulfate synthase 1 (PAPSS1) expression with clinical parameters and prognosis in esophageal squamous cell carcinoma. 2023 ·PubMed ·(unknown), (unknown), Xue Chen, Long Zhang, (unknown), Haoyang Zhang, Xiaoying Shen, (unknown), Mingmin Chen, Shunli Wang, (unknown)	1
6	Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251 2023 ·Nature Communications ·Jeffy George, Asisa Volz, Olusegun O. Onabajo, Sean B. Maynard, Sandra L. Bixler, Xiaoying Shen, Diego A. Vargas‐Inchaustegui, Marjorie Robert-Guroff, (unknown), Georgia D. Tomaras, David C. Montefiori, Gerd Sutter, Joseph J. Mattapallil	0
7	Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1 2023 ·Frontiers in Immunology ·Catarina E. Hioe, (unknown), (unknown), Daniel W. Heindel, Jéromine Klingler, (unknown), Christina C. Luo, Xunqing Jiang, Shilpi Pandey, (unknown), Philip Barnette, Maxim Totrov, Jiang Zhu, Arthur Nádas, Susan Zolla‐Pazner, Chitra Upadhyay, Xiaoying Shen, Xiang‐Peng Kong, Ann J. Hessell	1
8	Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines 2023 ·Journal of Virology ·(unknown), Nagarajan Raju, Prudence Kgagudi, Nelia P. Manamela, (unknown), (unknown), (unknown), Xiaoying Shen, (unknown), (unknown), Rebecca M. Lynch, David C. Montefiori, Simone I. Richardson, Penny L. Moore, Ivelin S. Georgiev	2
9	Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial 2023 ·International Journal of Infectious Diseases ·Nima S. Hejazi, Xiaoying Shen, Lindsay N. Carpp, David Benkeser, Dean Follmann, Holly Janes, Lindsey R. Baden, Hana M. El Sahly, Weiping Deng, Haiyu Zhou, Brett Leav, David C. Montefiori, Peter B. Gilbert	2
10	Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies 2022 ·Cell Reports ·Anusmita Sahoo, Edgar A. Hodge, Celia C. LaBranche, Tiffany M. Styles, Xiaoying Shen, Narayanaiah Cheedarla, (unknown), Gabriel Ozorowski, Wen-Hsin Lee, Andrew B. Ward, Georgia D. Tomaras, David C. Montefiori, Darrell J. Irvine, Kelly K. Lee, Rama Rao Amara	4
11	Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus Macaques 2022 ·Viruses ·Bapi Pahar, Wayne L. Gray, Marissa Fahlberg, Brooke Grasperge, Meredith Hunter, Arpita Das, (unknown), Pyone P. Aye, Faith Schiro, Krystle Hensley, (unknown), (unknown), Celia C. LaBranche, Xiaoying Shen, Georgia D. Tomaras, C. Todd DeMarco, David C. Montefiori, Patricia Kissinger, Preston A. Marx, Vicki Traina‐Dorge	4
12	Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans 2022 ·npj Vaccines ·(unknown), Margaret C. Carpenter, Rachel L. Spreng, Scott D. Neidich, (unknown), (unknown), Derrick Goodman, Sheetal Sawant, (unknown), (unknown), M. Juliana McElrath, Valerie Bekker, (unknown), Robin Flinko, George K. Lewis, Guido Ferrari, Georgia D. Tomaras, Xiaoying Shen, Margaret E. Ackerman	7
13	Towards a population-based threshold of protection for COVID-19 vaccines 2021 ·Vaccine ·David Goldblatt, Andrew Fioré-Gartland, Marina Johnson, Adam Hunt, Christopher Bengt, Dace Zavadska, (unknown), Jeremy Brown, Lesley Workman, Heather J. Zar, David C. Montefiori, Xiaoying Shen, Peter Dull, Stanley A. Plotkin, George R. Siber, Donna M. Ambrosino	87
14	SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines breakdown → 2021 ·Cell Host & Microbe ·Xiaoying Shen, Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler, Hyejin Yoon, Dapeng Li, Barton F. Haynes, (unknown), S. Gnanakaran, Nicolas Hengartner, Rolando Pajón, Gale Smith, Gregory M. Glenn, Bette Korber, David C. Montefiori	222
15	RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines 2020 ·Scientific Reports ·W. L. William Chang, Jesse D. Deere, (unknown), (unknown), Kawthar Machmach, Xiaoying Shen, Georgia D. Tomaras, Barbara L. Shacklett, Peter A. Barry, Dennis J. Hartigan-O’Connor, Ellen E. Sparger	5
16	Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques 2018 ·Journal of Virology ·Maria Dennis, Joshua Eudailey, Justin Pollara, (unknown), Kenneth Cronin, (unknown), Alan D. Curtis, Michael G. Hudgens, Genevieve G. Fouda, Guido Ferrari, Munir Alam, Koen K. A. Van Rompay, Kristina De Paris, Sallie R. Permar, Xiaoying Shen	10
17	Capacity for Infectious HIV-1 Virion Capture Differs by Envelope Antibody Specificity 2014 ·Journal of Virology ·Pinghuang Liu, LaTonya D. Williams, Xiaoying Shen, Mattia Bonsignori, Nathan Vandergrift, R. Glenn Overman, M. Anthony Moody, Hua-Xin Liao, Daniel J Stieh, (unknown), Audrey L. French, Thomas J. Hope, Robin J. Shattock, Barton F. Haynes, Georgia D. Tomaras	28
18	HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial 2014 ·Journal of Clinical Investigation ·Pierre‐Alexandre Bart, Yunda Huang, Shelly Karuna, (unknown), Julien Gaillard, Nidhi Kochar, Xiaoying Shen, Mary Allen, S.-W Ding, John Hural, Hua-Xin Liao, Barton F. Haynes, Barney S. Graham, Peter B. Gilbert, M. Juliana McElrath, David C. Montefiori, Georgia D. Tomaras, Giuseppe Pantaleo, Nicole Frahm	18
19	Vaccination with Vaxfectin ^® adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia 2013 ·Human Vaccines & Immunotherapeutics ·Viraj Kulkarni, Margherita Rosati, Antonio Valentin, Rashmi Jalah, Candido Alicea, Lei Yu, Yongjun Guan, Xiaoying Shen, Georgia D. Tomaras, Celia C. LaBranche, David C. Montefiori, Carmela Irene, (unknown), Abraham Pinter, Seán M. Sullivan, George N. Pavlakis, Barbara K. Felber	10
20	Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-α plasmids preserves global CD4 T lymphocyte function after challenge with FIV 2009 ·Vaccine ·(unknown), (unknown), Xiaoying Shen, (unknown), Gregg A. Dean, Ellen E. Sparger	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact